These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33152028)

  • 21. Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.
    Aiello Bowles EJ; Crane PK; Walker RL; Chubak J; LaCroix AZ; Anderson ML; Rosenberg D; Keene CD; Larson EB
    J Alzheimers Dis; 2019; 68(3):1071-1083. PubMed ID: 30909217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
    Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
    Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability and Coupling of Olfactory Identification and Episodic Memory in Older Adults.
    Knight JE; Bennett DA; Piccinin AM
    J Gerontol B Psychol Sci Soc Sci; 2020 Feb; 75(3):577-584. PubMed ID: 29762752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Alzheimer's Cognitive Resilience Score: A Comparative Study of Machine Learning Models Using RNA-seq Data.
    Kitani A; Matsui Y
    bioRxiv; 2024 Aug; ():. PubMed ID: 39253457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
    O'Caoimh R; Gao Y; Svendrovski A; Illario M; Iaccarino G; Yavuz BB; Kehoe PG; Molloy DW
    J Alzheimers Dis; 2019; 68(4):1499-1510. PubMed ID: 30909214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of effects of cognitive reserve on performance in probable Alzheimer's disease and in subjective cognitive decline.
    Montemurro S; Mondini S; Arcara G
    Neuropsychology; 2021 Nov; 35(8):876-888. PubMed ID: 34553970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive resilience and severe Alzheimer's disease neuropathology.
    Ahangari N; Fischer CE; Schweizer TA; Munoz DG
    Aging Brain; 2023; 3():100065. PubMed ID: 36911256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations Between Personality Traits and Cognitive Resilience in Older Adults.
    Graham EK; James BD; Jackson KL; Willroth EC; Boyle P; Wilson R; Bennett DA; Mroczek DK
    J Gerontol B Psychol Sci Soc Sci; 2021 Jan; 76(1):6-19. PubMed ID: 32969474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer's Disease Neuropathology and Cognition.
    Malek-Ahmadi M; Lu S; Chan Y; Perez SE; Chen K; Mufson EJ
    J Alzheimers Dis Parkinsonism; 2017; 7(6):. PubMed ID: 29423338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of MIND diet with cognitive resilience to neuropathologies.
    Wagner M; Agarwal P; Leurgans SE; Bennett DA; Schneider JA; Capuano AW; Grodstein F
    Alzheimers Dement; 2023 Aug; 19(8):3644-3653. PubMed ID: 36855023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition.
    Negash S; Wilson RS; Leurgans SE; Wolk DA; Schneider JA; Buchman AS; Bennett DA; Arnold SE
    Curr Alzheimer Res; 2013 Oct; 10(8):844-51. PubMed ID: 23919768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
    Hill NL; Mogle J
    BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to change and prediction of global change for the Alzheimer's Questionnaire.
    Malek-Ahmadi M; Chen K; Davis K; Belden CM; Powell J; Jacobson SA; Sabbagh MN
    Alzheimers Res Ther; 2015 Jan; 7():1. PubMed ID: 26584966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
    Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
    J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.